Discussion and inspiration about learning in Division of Esophageal Surgery of National Cancer Center Hospital in Japan

韩泳涛,戴亮,大幸宏幸,郭旭峰,冷雪峰,侯广杰
DOI: https://doi.org/10.3877/cma.j.issn.2095-8773.2021.01.10
2021-01-01
Abstract:Esophageal cancer is a malignant tumor with high morbidity and mortality in the world. Squamous cell carcinoma accounts for more than 90% of esophageal cancer incidence in China and Japan. The two countries have similarities and differences in the surgical treatment, comprehensive treatment concept and practice of esophageal squamous cell carcinoma. It is worth learning from such aspects as minimally invasive surgery, comprehensive treatment, and clinical research. Dr. Leng was fortunate to visit the representative esophageal cancer surgery center in Japan—the National Cancer Center Central Hospital. The colleagues who visited the National Cancer Center simultaneously summarized the Japanese esophageal cancer surgery and the research based on clinical practice, academic conferences, and expert interviews. The current comprehensive treatment situation, hoping to reference colleagues engaged in esophageal cancer surgery and comprehensive treatment.
What problem does this paper attempt to address?